Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
mccormick.northwestern.edu

Monkeypox Rapid PCR Test in Development

Last spring, a rapid polymerase chain reaction (PCR) test for COVID-19 — developed by Northwestern University spinoff company Minute Molecular Diagnostics — received emergency use authorization (EUA) ...
The Herald Journal

Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

Joint development strategy has been developed to address international deployment requirements if current outbreak continues or expands globally ...
pharmaphorum

Roche develops Bundibugyo Ebola test in six days

A PCR diagnostic developed by Roche for the Bundibugyo form of Ebola is being offered to health systems at the front lines of ...
Medical Device Network on MSN

Roche develops RUO PCR assay to detect rare Ebola Bundibugyo virus

TIB MOLBIOL developed the test using its "rapid response" library, with 15,000 designs and 3,000 controls.
Scientific American

Inside the race to develop a hantavirus PCR test

Researchers at the Nebraska Public Health Laboratory worked round the clock to develop a test for the Andes virus at the center of the deadly cruise ship outbreak ...
News Medical

Revolutionising point-of-care molecular diagnostics with a sub 10 minute PCR test

Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...
Medical Device Network on MSN

Countable Labs raises $26M for PCR technology advancement

Countable Labs claims that its Countable PCR technology is “at least 10 times” more sensitive than conventional PCR.
News Medical

Saliva-based self-testing platform detects SARS-CoV-2 with the same level of sensitivity as PCR tests

PCR tests, also called molecular tests or nucleic acid tests, are considered the gold standard in detecting the presence of SARS-CoV-2, the virus that gives rise to COVID-19. However, they can take a ...